The 1st Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) Shanghai, China, June 2-5, 2011 |
|
| |
| Friday, June 3, 2011 |
 |
|
|
HALL A |
|
08:30-10:00 |
Plenary Session 1
FUTURE THERAPY |
|
Diabetes prevention vs. early diagnosis in Asia and worldwide Metabolic benefits of incremental weight loss Diabetes in Asia – Is it only the beta cell? Recent trial to prevent CV disease: Is this the answer or has it created more questions?
|
|
10:30-12:30 |
Session 2
FIRST LINE THERAPY FOR T2D AFTER METFORMIN FOCUS ON ASIA |
|
|
Glucosidan INH - First line therapy Vs. metformin
GLP1/DPP4 INH vs. Sulfonylurea / Insulin / TZDs Pro / Con
|
|
13:30-15:30 |
Session 3
INSULIN THERAPY IN T2D |
|
Initiation of insulin:
Not too early / Not too late
Combinations of Oral Hypoglycemic (OAD) with long-acting analogs
Place of TZD in Asian diabetic patients |
|
16:00-17:30
|
Session 4
THERAPEUTIC APPROACH TO YOUTH WITH T2DM? IS IT EFFICIENT FOR ASIANS? |
|
Insulin, metformin TZD, glucosidase INH
Combination therapy and lifestyle modifications
|
|
HALL B |
|
10:30-12:30 |
Session 5
|
|
|
|
|
Session 6
TREATMENT GOALS IN DIABETES |
|
Should we aim to normalize A1c? Pro / Con
The glucotriad: Is glucose variability a cardiovascular (CV) risk factor in its own right? Pro / Con |
|
16:00-17:30 |
Session 7
PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY |
|
Key role of glucose control: Pro / Con
Key role of blood pressure (BP) control: Pro / Con
Key role of lipid control: Pro / Con
|
|
HALL C |
|
10:30-12:30 |
Session 8
CARDIOMETABOLIC RISK ASSESSMENT AND METABOLIC SYNDROME CONTROVERSIES |
|
|
|
13:30-15:30 |
Session 9
OPTIMIZING DIABETES THERAPY |
|
Programmed insulin dose calculation: Pro / Con Benefit of self-monitoring glucose control:
Pro / Con Continuous glucose monitoring (CGM): For whom will it be beneficial?
|
|
16:00-17:30 |
Session 10 CARDIOVASCULAR RISK IN DIABETES FOCUS ON GENETICS IN ASIA |
|
Hyperglycemia and CVD Dyslipemia and CVD Hypertension and CVD Inflammation and CVD Cultural obesity
|
|
|
|
|